Skip to main content
OpenTrials
Completed

NCT Number: NCT05342363

Mechanical Cardiopulmonary Resuscitation During Treatment of Acute Respiratory Failure Through Extracorporeal Membrane Oxygenation.

In-hospital cardiovascular arrest is associated with poor outcome despite prompt treatment and optimal on-site resources. The population of patients treated by venovenous extracorporeal membrane oxygenation (vv-ECMO) due to pulmonary failure is a very challenging group of patients. To date, the frequency, causes and outcome of cardiovascular arrest in these patients have not been studied. We are aiming to conduct a retrospective observational study of all vv-ECMO patients treated at our ARDS centre.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Resuscitation Venovenous Extracorporeal Membrane Oxygenation

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Frankfurt

Frankfurt am Main, Hesse, 60590, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients treated with veno-venous extracorporeal membrane oxygenation (vv-ECMO) due to respiratory failure during acute respiratory distress syndrome (ARDS).

Exclusion criteria

Patients treated with veno-arterial extracorporeal membrane oxygenation (va-ECMO)

Treatment and study plan

Primary outcomes

  1. Survival of mechanical cardiovascular resuscitation

    Time frame: During the intensive care stay ( usually between 2 and 8 weeks)

    Survival of mechanical cardiovascular resuscitation

Secondary outcomes

  1. Incidence of cardiovascular resuscitation i

    Time frame: During the observation period 2019-2022

    Incidence of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation.

  2. Complications of resuscitation treatments

    Time frame: During the intensive care stay ( usually between 2 and 8 weeks)

    Complications of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation

Sponsors and collaborators

Lead sponsor

Goethe University

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Apr 22, 2022
Registry last updated
Aug 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.